SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-24-020964
Filing Date
2024-06-21
Accepted
2024-06-21 16:12:07
Documents
8
Effectiveness Date
2024-06-21
Reference 429
333-271053

Document Format Files

Seq Description Document Type Size
1 FORM S-8 nby20240620_s8.htm S-8 82617
2 EXHIBIT 4.2 ex_691229.htm EX-4.2 1601
3 EXHIBIT 5.1 ex_691230.htm EX-5.1 11992
4 EXHIBIT 23.1 ex_691435.htm EX-23.1 2457
5 EXHIBIT FILING FEES ex_691232.htm EX-FILING FEES 15739
6 cert01.jpg GRAPHIC 134609
7 cert02.jpg GRAPHIC 118555
8 squirelogo.jpg GRAPHIC 4423
  Complete submission text file 0001437749-24-020964.txt   470690
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280388 | Film No.: 241060299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)